Clinical Trial Update: Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in Uganda evaluating misoprostol for prevention of postpartum hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Mbarara University of Science and Technology | Conditions: Post Partum Hemorrhage | Phase 3 | Status: COMPLETED